Seminoma

18 clinical trials · Condition

Record	Firm	Date
Radiotherapy vs Observation for Post Chemotherapy Residual Mass in Advanced Seminoma (NCT05142982)	Tata Memorial Centre	2021-12-01
A Study of miRNA 371 in Patients With Germ Cell Tumors (NCT04435756)	SWOG Cancer Research Network	2020-07-28
Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma (NCT03937843)	Swiss Cancer Institute	2019-07-29
Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors (NCT03158064)	Memorial Sloan Kettering Cancer Center	2017-05-15
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013)	National Cancer Institute (NCI)	2017-01-30
MicroRNA as Markers in Testicular Cancer (NCT04914026)	Haukeland University Hospital	2016-12-31
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors (NCT02375204)	Alliance for Clinical Trials in Oncology	2015-08-06
Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer (NCT02341989)	St. Olavs Hospital	2015-04-08
Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma (NCT01887340)	Gustave Roussy, Cancer Campus, Grand Paris	2013-06-01
Therapy De-escalation in Seminoma Stage IIA/B (NCT01593241)	Swiss Cancer Institute	2012-06-15
Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients (NCT00705094)	AHS Cancer Control Alberta	2008-09-01

Every clearance here is in the API, with alerts when new ones post.